Self-Assessment of Medical Abortion Outcome Using Serial Multi-level Pregnancy Tests
Not Applicable
Completed
- Conditions
- Medical Abortion
- Interventions
- Behavioral: Self-assessment
- Registration Number
- NCT02570204
- Lead Sponsor
- Gynuity Health Projects
- Brief Summary
This study aims to investigate the effectiveness and acceptability of the multi-level pregnancy test for self-assessment of abortion outcomes, without a routine provider contact.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 343
Inclusion Criteria
- Gestational age of less than or equal to 63 days
- Determined by the site investigator or designee to be fully eligible for medical abortion with mifepristone followed by misoprostol according to the site's standard criteria
- Willing to use the MLPT at home
- 11-56 years old
- Willing and able to comply with study procedures
- In the judgement of the site investigator, she is capable of giving informed consent and she has signed the study informed consent or assent form
Exclusion Criteria
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Self-assessment of abortion outcome Self-assessment Patients enrolled in the study will self-assess the outcomes of their medical abortion with the aid of a multi-level pregnancy test (MLPT) which they will perform at home.
- Primary Outcome Measures
Name Time Method Proportion of subjects who fail to contact the clinic when indicated within two weeks after taking the mifepristone One month
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (3)
Carafem
🇺🇸Chevy Chase, Maryland, United States
Presidential Women's Center
🇺🇸West Palm Beach, Florida, United States
Philadelphia Women's Center
🇺🇸Philadelphia, Pennsylvania, United States